Role of statins in Alzheimer's disease: a retrospective meta-analysis for commonly investigated clinical parameters in RCTs

References

• Scarpini E, Cogiamanian F. Alzheimer's disease: from molecular pathogenesis to innovative therapies. Expert Rev Neurother 2003;3:619–30.
   PubMedGoogle Scholar
• Nygaard HB, Strittmatter SM. Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. Arch Neurol 2009;66:1325–8.
   Google Scholar
• Minino A, Murphy SL, Xu J, Kochanek K. Deaths: final data for 2008. National vital statistics reports. Hyattsville, MD.; National Center for Health Statistics. 2011.
   Google Scholar
• Cole SL, Vassar R. The Alzheimer's disease beta-secretase enzyme, BACE1. Mol Neurodegener 2007;2:22.
   PubMed Web of Science ®Google Scholar
• Glenner CG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemis Biophys Res Comm 1984;20:885–90.
   Google Scholar
• Ehehalt R, Keller P, Haass C, Amyloidogenic processing of the alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003;160:113–23.
   PubMed Web of Science ®Google Scholar
• Reid PC, Urano Y, Kodama T, Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins. J Cell Mol Med 2007;11:383–92.
   PubMed Web of Science ®Google Scholar
• Chu LW. Alzheimer's disease: early diagnosis and treatment. Hong Kong Med J 2012;18:228–37.
   PubMed Web of Science ®Google Scholar
• Scarpini E, Scheltens P, Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol 2003;2:539–47.
   PubMed Web of Science ®Google Scholar
• Sánchez-Ferro A, Benito-León J, Mitchell AJ, Bermejo-Pareja F. A review of the potential therapeutic role of statins in the treatment of Alzheimer's disease: current research and opinion. Neuropsychiatr Dis Treat 2013;9:55–63.
   PubMed Web of Science ®Google Scholar
• Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 2011;68(11):1385–92.
   PubMedGoogle Scholar
• Wolozin B. Statins and therapy of Alzheimer's disease: questions of efficacy versus trial design. Alzheimers Res Ther 2012 Jan 16;4(1):3.
   PubMedGoogle Scholar
• Burgos JS, Benavides J, Douillet P How statins could be evaluated successfully in clinical trials for Alzheimer's disease? Am J Alzheimers Dis Other Demen 2012;27(3):151–3.
   PubMed Web of Science ®Google Scholar
• Wolozin B, Kellman W, Ruosseau P Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch.Neurol. 2000;57:1439–43.
   PubMed Web of Science ®Google Scholar
• Jick H, Zornberg GL, Jick SS, Statins and the risk of dementia. Lancet 2000;356:1627– 31.
   PubMed Web of Science ®Google Scholar
• Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv 2008;1:211–7.
   PubMed Web of Science ®Google Scholar
• Neyeloff JL, Fuchs CS, Moreira LB. Meta-analyses and Forest plots using a Microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes 2012;5:52.
   PubMedGoogle Scholar
• Packard CJ, Westendorp RG, Stott DJ, Association between apolipoprotein E4 and cognitive decline in elderly adults. J Amer Geriat Soc 2007;11:1777–85.
   Google Scholar
• Shepherd J, Blauw GJ, Murphy MB, Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623–30.
   PubMed Web of Science ®Google Scholar
• Shepherd J, Blauw GJ, Murphy MB, The design of a prospective study of pravastatin in the elderly at risk (PROSPER). Am J Cardiol 1999;84:1192–7.
   PubMed Web of Science ®Google Scholar
• Simons M, Schwarzler F, Lutjohann D, Treatment with Simvastatin in normocholesterolaemic patients with Alzheimer's disease: a 26-week randomized, placebo- controlled, doubleblind trial. Annals Neurol 2002;52:346–50.
   PubMed Web of Science ®Google Scholar
• Sparks DL, Connor DJ, Sabbagh MN, Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial. Acta Neurol Scan 2006;114:3–7.
   Web of Science ®Google Scholar
• Sparks DL, Sabbagh MN, Connor D, Statin therapy in Alzheimer's disease. Acta Neurol Scandinav 2006;114:78–86.
   Google Scholar
• Jones RW, Kivipelto M, Feldman H. LEADe Investigators. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Alzheimers Dement 2008;4:145–53.
   PubMed Web of Science ®Google Scholar
• Feldman H, Jones RW, Kivipelto M, The LEADe study: a randomized, controlled trial investigating the effect of atorvastatin on cognitive and global function in patients with mild-to-moderate Alzheimer's disease receiving background therapy of donepezil. Neurol 2008;71:153–6.
   Google Scholar
• Sano M, Bell KL, Galasko D, A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurol 2011;77:556–63.
   PubMed Web of Science ®Google Scholar
• Fassbender K, Simons M, Bergmann C, Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 2001;98:5856–61.
   PubMed Web of Science ®Google Scholar
• Refolo LM, Malester B, LaFrancois J, Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol l Disord 2000;7:321–31.
   PubMed Web of Science ®Google Scholar
• McGuinness B, Passmore P. Can statins prevent or help treat Alzheimer's disease? J Alzheimers Dis 2010;20:925–33.
   PubMed Web of Science ®Google Scholar
• McGuinness B, Craig D, Bullock R, Statins for the prevention of dementia. Cochrane Database Syst Rev 2009;15.
   Google Scholar
• McGuinness B, Hare JO’, Craig D, Statins for the treatment of dementia. Cochrane Database Syst Rev 2010;8.
   Google Scholar